• About Us
  • Contact Us
  • Submit News Release
Saturday, April 1, 2023
No Result
View All Result
submit news
Oman News Club
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
No Result
View All Result
Oman News Club
Submit PR
Home PRESS RELEASES

Oncology Biosimilars Market 2022: Key Players, Drivers, Trends Forecasts to 2028

by Newsroom Editor
September 30, 2022
Share on FacebookShare on Twitter


(EMAILWIRE.COM, September 30, 2022 ) The global oncology biosimilars market size was valued at USD 3.05 billion in 2021 and is poised to grow at a significant CAGR of 29.0% during the forecast period 2022-28. A biosimilar is a biological product that strongly matches and is the same as a reference product that has already received approval. These are less expensive than things that are branded or approved. The patents on a number of oncology biologics have already expired, and others may soon follow. As additional products lose their patent protection, biosimilars are expected to become more popular. These patent expirations are anticipated to be advantageous for top generic firms including Allergan Plc., Teva Pharmaceutical Industries Ltd., Mylan N.V., and Sandoz (a branch of Novartis International AG), positioning them as market leaders in oncology biosimilars.

View Complete Report: https://precisionbusinessinsights.com/market-reports/oncology-biosimilars-market/

The Oncology Biosimilars Market Growth Factors:

Globally, the incidence of cancer has increased throughout time as a result of environmental deterioration and an aging population. The burden on healthcare systems around the world has increased as a result of these variables and the rising expense of cancer treatment. As a result, government agencies from many nations are encouraging the use of biosimilars as a way to reduce costs. For instance, the United States Food and Drug Administration (USFDA) has created educational resources about biosimilars for doctors and patients. Aside from this, earlier and more widespread use of therapy as well as increased patient access have both been connected to the availability of economical medication. In addition, oncology biosimilars may improve industry competitiveness, which could result in a decrease in the cost of biological products.

The Oncology Biosimilars Market Trends

• Globally, there are more cases of cancer due to environmental pollution, climate change, UV exposure, biological and chemical pollution in food and water, and epigenetic and genetic factors.

• Globally, the approval of biosimilars has been rising as a result of evolving legislation and growing pressure on healthcare systems to make treatment more accessible to all patients.

The Oncology Biosimilars Market Segmentation:

The Global Oncology Biosimilars Market on the basis of Drug Type, the market is categorized into Immunomodulators, Monoclonal Antibody, G-CSF, Hematopoietic Agents, and Others. On the basis of Cancer Type, the market is categorized into Lung Cancer, Cervical Cancer, Colorectal Cancer, Breast Cancer, and Others.

Request Sample Of The Report: https://precisionbusinessinsights.com/request-sample?product_id=19301

The Oncology Biosimilars Market Regional Analysis

During the projection period, the global market in Europe is anticipated to have the greatest revenue share. The expiration of the patent protection for previous reference biologic products, the emergence of new biosimilars by drug companies active in this region, and the rise in the prevalence of immune- and inflammatory-related chronic diseases are the main drivers anticipated to propel market revenue growth. Other factors that are anticipated to contribute to the market’s revenue growth include the adoption of regulations that will quicken the medication approval procedure and the strong presence of market participants in Europe.

The major players operating in the oncology biosimilars market are Biocoin, Celltrion inc., Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Pfizer inc., Apotex inc., Teva Pharmaceutical Industries Ltd.

Related Reports:

Biosimilars Market: By-Drug Class (Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others), By Application (Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and Others), By Manufacturing Type (Captive and Out-sourcing), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

https://precisionbusinessinsights.com/market-reports/global-biosimilars-market/

Antidiabetic Biosimilars Market: By Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, α-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others),By Disease Type (Type-I Diabetes, Type-II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

https://precisionbusinessinsights.com/market-reports/anti-diabetic-biosimilars-market/

Oncology Information System Market: By Type [Services (Consulting Services, Implementation Services, Post Sale and Maintenance) (Software (Treatment Planning, Patient Information)] By Application (Medical Oncology, Surgical Oncology, Radiation Oncology) By End-User (Hospitals, Oncology Clinics, Research Centres, Oncology Institutes) By Geography

https://precisionbusinessinsights.com/market-reports/oncology-information-system-market/

Precision Oncology Market: By Type (Consumable, Instruments, Services), by End User (Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, CROs) and Geography

https://precisionbusinessinsights.com/market-reports/precision-oncology-market/

About Precision Business Insights:

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business InsightsTM | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com

Kemp House, 152 – 160 City Road, London EC1V 2NX

Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747



Source link

Previous Post

Biostimulants Market Rising Demand For Biological Ingredients And Fewer Synthetic Chemicals

Next Post

Identify the Weather Data Service Market Growth Opportunities by 2027

Next Post

Identify the Weather Data Service Market Growth Opportunities by 2027

No Result
View All Result

Categories

  • BUSINESS (24)
  • ENERGY (37)
  • FINANCE (37)
  • HEALTHCARE (37)
  • LIFESTYLE (37)
  • MIDDLE EAST (85)
  • PRESS RELEASES (693)
  • REAL ESTATE (37)
  • TECH (22)
  • TRAVEL (20)

Recent.

Indian Embassy in Oman conducts yoga session on board INS Teg – India Narrative

March 30, 2023

Which countries have escaped the middle-income trap? – Yahoo Finance

March 30, 2023

Focus on the quality and quantity of sleep during Ramadan – Times of Oman

March 30, 2023

Subscribe to our Newsletter

    Share Us

    Categories

    Categories
    • BUSINESS
    • ENERGY
    • FINANCE
    • HEALTHCARE
    • LIFESTYLE
    • MIDDLE EAST
    • PRESS RELEASES
    • REAL ESTATE
    • TECH
    • TRAVEL

    Recent News

    Recent Posts
    • Indian Embassy in Oman conducts yoga session on board INS Teg – India Narrative
    • Which countries have escaped the middle-income trap? – Yahoo Finance
    • Focus on the quality and quantity of sleep during Ramadan – Times of Oman
    • Oman real estate: $1.2bn of property deals in February – Arabian Business

    About Us

    OmanNews.Club™ reports, publishes and aggregates business, Tech and lifestyle news on Oman the Middle East and the North Africa (MENA). 

    We provide press release distribution to media outlets in Oman, Arab countries and the (MENA) regions. Submit a press release or contact us today.

    Oman News is part of GroupWeb Media Network. @ 2023 GroupWeb Media LLC

    About Us / Contact Us / Submit News Release

    No Result
    View All Result
    • About Us
    • Cart
    • Checkout
    • Contact Us
    • Home
    • My account
    • Shop
    • Submit News Release
    • Test page

    Oman News is part of GroupWeb Media Network. @ 2023 GroupWeb Media LLC